活血化瘀方药治疗血瘀证慢性阻塞性肺疾病急性加重期的临床疗效评价  

Clinical efficacy of the Huoxue Huayu decoction on the Xueyu syndrome of acute exacerbation chronic obstructive pulmonary disease

作　　者：宋宏雷 

机构地区：[1]湖北省襄阳市谷城县中医院,湖北襄阳441700

出　　处：《中医临床研究》2017年第28期94-95,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:评价活血化瘀方药治疗血瘀证慢性阻塞性肺疾病急性加重期的临床效果。方法:随机选取2014年1月-2015年12月我院收治的80例慢性阻塞性肺疾病急性加重期患者的临床资料进行分析。结果:观察组治疗总有效率为92.5%,对照组治疗总有效率为70.0%,观察组总有效率明显高于对照组;观察组全血黏度改善情况优于对照组;观察组肺功能FEV1、FEV1/FVC%等指标改善情况明显优于对照组,两组对比差异显著(P<0.05)。结论:活血化瘀方药治疗血瘀证慢性阻塞性肺疾病急性加重期效果更为理想,且明显改善了患者全血黏度和肺功能指标,值得推广应用。Objective:To evaluate efficacy of the Huoxue Huayu decoction on the Xueyu syndrome of acute exacerbation chronic obstructive pulmonary disease.Methods:80cases of chronic obstructive pulmonary disease were analyzed and divided into the control group and observation group,40cases in each.The control group took conventional western medicine;the observation group received TCM medicine more.Results:The total efficiency was92.5%in the observation group,better than70.0%in the control group.The improvement of whole blood viscosity,and the improvement of FEV1and FEV1/FVC%in the observation group were significantly better than the control group(P<0.05).Conclusion:The Huoxue Huayu decoction is more effective on AECOPD,by improving the blood viscosity and pulmonary function,is worthy of promotion.

关 键 词：活血化瘀方药 血瘀证 慢性阻塞性肺疾病 

分 类 号：R256.1[医药卫生—中医内科学]